跳至主要内容
临床试验/NCT05554705
NCT05554705终止不适用

A Lifestyle Intervention for Rheumatoid Arthritis: Effect of an Intensive Therapeutic Lifestyle Change Program on Inflammatory Markers and Clinical Outcomes

Blue Cross Blue Shield of Vermont1 个研究点 分布在 1 个国家目标入组 114 人开始时间: 2023年1月2日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
发起方
入组人数
114
试验地点
1
主要终点
Change in HAQ-2 score

研究概览

简要总结

The main purpose of this study is to assess whether adding a multifaceted lifestyle intervention to the standard best practice of care can be more effective than standard best practices alone for treating Rheumatoid Arthritis.

详细描述

The main purpose of this study is to assess whether adding a multifaceted lifestyle intervention to the standard best practice of care can be more effective than standard best practices alone for treating Rheumatoid Arthritis. If a lifestyle intervention is effective, we expect to see improvement in functional status and decreased health care costs to the study participant and the insurer.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •BCBSVT members who also carry the prescription benefit with BCBSVT (due to the need for tracking prescription costs).
  • •BCBSVT membership for minimum of 12 months prior to start of study (due to the need for tracking prescription costs before and after intervention).
  • •Age 18 or older
  • •Medical diagnosis of RA

排除标准

  • •Currently taking warfarin (since fluctuating amounts of green leafy vegetable intake can adversely affect INR levels and because we will be asking participants to increase the amount of green leafy vegetables they consume)
  • •Malignancy currently undergoing treatment (with further planned treatment at the time of enrollment) since patients undergoing cancer treatment often need to stop RA medications in order to improve immune function, and thus could be a confounder.
  • •Food allergy (including reactions such as hives, wheezing, difficulty breathing, fainting, or anaphylaxis)

研究组 & 干预措施

experimental

Experimental

standard of care + lifestyle intervention

干预措施: Intensive Lifestyle intervention (Behavioral)

control

No Intervention

no intervention (control group)

结局指标

主要结局

Change in HAQ-2 score

时间窗: Up to 24 months

The HAQ-II is a validated and reliable tool used frequently by rheumatologists evaluating patients with RA (Wolfe et al, 2004). It is an indicator of quality of life as well as functional status. It is also a predictor of premature mortality.

Change in serum C-Reactive Protein

时间窗: Up to 24 months

CRP is a reliable marker of acute and chronic inflammation (Sproston and Ashworth, 2018).

次要结局

  • Change in dosage of RA-related medications(Up to 24 months)
  • Change in blood pressure(Up to 24 months)
  • Change in weight(Up to 24 months)
  • Change in serum LDL cholesterol(Up to 24 months)
  • Change in serum HbA1c(Up to 24 months)
  • Change in RA-related costs for the study participant(Up to 24 months)
  • Change in RA-related costs to the insurer(Up to 24 months)
  • Change in the number of medications required to treat RA(Up to 24 months)
  • Change in serum total cholesterol(Up to 24 months)
  • Change in BMI(Up to 24 months)

研究者

发起方
Blue Cross Blue Shield of Vermont
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验